Cargando…

Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan

To date, over 30 genes with mutations causing limb-girdle muscle dystrophy have been described. Dysferlinopathies are a form of limb-girdle muscle dystrophy type 2B with an incidence ranging from 1:1,300 to 1:200,000 in different populations. In 1996, Dr. S. N. Illarioshkin described a family from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Umakhanova, Zoya R., Bardakov, Sergei N., Mavlikeev, Mikhail O., Chernova, Olga N., Magomedova, Raisat M., Akhmedova, Patimat G., Yakovlev, Ivan A., Dalgatov, Gimat D., Fedotov, Valerii P., Isaev, Artur A., Deev, Roman V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340769/
https://www.ncbi.nlm.nih.gov/pubmed/28337173
http://dx.doi.org/10.3389/fneur.2017.00077
_version_ 1782512864080166912
author Umakhanova, Zoya R.
Bardakov, Sergei N.
Mavlikeev, Mikhail O.
Chernova, Olga N.
Magomedova, Raisat M.
Akhmedova, Patimat G.
Yakovlev, Ivan A.
Dalgatov, Gimat D.
Fedotov, Valerii P.
Isaev, Artur A.
Deev, Roman V.
author_facet Umakhanova, Zoya R.
Bardakov, Sergei N.
Mavlikeev, Mikhail O.
Chernova, Olga N.
Magomedova, Raisat M.
Akhmedova, Patimat G.
Yakovlev, Ivan A.
Dalgatov, Gimat D.
Fedotov, Valerii P.
Isaev, Artur A.
Deev, Roman V.
author_sort Umakhanova, Zoya R.
collection PubMed
description To date, over 30 genes with mutations causing limb-girdle muscle dystrophy have been described. Dysferlinopathies are a form of limb-girdle muscle dystrophy type 2B with an incidence ranging from 1:1,300 to 1:200,000 in different populations. In 1996, Dr. S. N. Illarioshkin described a family from the Botlikhsky district of Dagestan, where limb-girdle muscle dystrophy type 2B and Miyoshi myopathy were diagnosed in 12 members from three generations of a large Avar family. In 2000, a previously undescribed mutation in the DYSF gene (c.TG573/574AT; p. Val67Asp) was detected in the affected members of this family. Twenty years later, in this work, we re-examine five known and seven newly affected family members previously diagnosed with dysferlinopathy. We observed disease progression in family members who were previously diagnosed and noted obvious clinical polymorphism of the disease. A typical clinical case is provided.
format Online
Article
Text
id pubmed-5340769
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53407692017-03-23 Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan Umakhanova, Zoya R. Bardakov, Sergei N. Mavlikeev, Mikhail O. Chernova, Olga N. Magomedova, Raisat M. Akhmedova, Patimat G. Yakovlev, Ivan A. Dalgatov, Gimat D. Fedotov, Valerii P. Isaev, Artur A. Deev, Roman V. Front Neurol Neuroscience To date, over 30 genes with mutations causing limb-girdle muscle dystrophy have been described. Dysferlinopathies are a form of limb-girdle muscle dystrophy type 2B with an incidence ranging from 1:1,300 to 1:200,000 in different populations. In 1996, Dr. S. N. Illarioshkin described a family from the Botlikhsky district of Dagestan, where limb-girdle muscle dystrophy type 2B and Miyoshi myopathy were diagnosed in 12 members from three generations of a large Avar family. In 2000, a previously undescribed mutation in the DYSF gene (c.TG573/574AT; p. Val67Asp) was detected in the affected members of this family. Twenty years later, in this work, we re-examine five known and seven newly affected family members previously diagnosed with dysferlinopathy. We observed disease progression in family members who were previously diagnosed and noted obvious clinical polymorphism of the disease. A typical clinical case is provided. Frontiers Media S.A. 2017-03-08 /pmc/articles/PMC5340769/ /pubmed/28337173 http://dx.doi.org/10.3389/fneur.2017.00077 Text en Copyright © 2017 Umakhanova, Bardakov, Mavlikeev, Chernova, Magomedova, Akhmedova, Yakovlev, Dalgatov, Fedotov, Isaev and Deev. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Umakhanova, Zoya R.
Bardakov, Sergei N.
Mavlikeev, Mikhail O.
Chernova, Olga N.
Magomedova, Raisat M.
Akhmedova, Patimat G.
Yakovlev, Ivan A.
Dalgatov, Gimat D.
Fedotov, Valerii P.
Isaev, Artur A.
Deev, Roman V.
Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan
title Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan
title_full Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan
title_fullStr Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan
title_full_unstemmed Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan
title_short Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan
title_sort twenty-year clinical progression of dysferlinopathy in patients from dagestan
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340769/
https://www.ncbi.nlm.nih.gov/pubmed/28337173
http://dx.doi.org/10.3389/fneur.2017.00077
work_keys_str_mv AT umakhanovazoyar twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan
AT bardakovsergein twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan
AT mavlikeevmikhailo twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan
AT chernovaolgan twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan
AT magomedovaraisatm twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan
AT akhmedovapatimatg twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan
AT yakovlevivana twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan
AT dalgatovgimatd twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan
AT fedotovvaleriip twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan
AT isaevartura twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan
AT deevromanv twentyyearclinicalprogressionofdysferlinopathyinpatientsfromdagestan